Interested in promotions? | Click here >>
Activators & Inhibitors
Chemical Modulators

CHIR-99021 #54290

Reviews ()
Citations (0)
other Image 1 - CHIR-99021

Western blot analysis of extracts from 293 cells, untreated (-) or treated with Calyculin A #9902 (50 nM, 1 hr; +) with or without pretreating the cells with CHIR-99021 (10 μM, 1 hr; +), using Phospho-c-Myc (Thr58) (E4Z2K) Rabbit mAb #46650 (upper), c-Myc (E5Q6W) Rabbit mAb #18583 (middle), or β-Actin (D6A8) Rabbit mAb #8457 (lower).

other Image 2 - CHIR-99021

Chemical structure of CHIR-99021.

Product Usage Information

CHIR-99021 is supplied as a lyophilized powder. For a 10 mM stock, reconstitute 5 mg of powder in 1.07 ml of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.


Store lyophilized at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Product Description

Molecular Weight 465.3 g/mol


Molecular Formula


CAS 252917-06-9
Solubility Soluble in DMSO at 25 mg/ml with slight warming.


CHIR-99021, also known as CT-99021, is a potent and selective inhibitor of glycogen synthase kinase-3β (GSK-3β) and GSK-3α with IC50 values of 6.7 and 10 nM, respectively. This small compound has been shown to have >500-fold selectivity for GSK-3 when tested against 20 different protein kinases (1). Studies have shown that treating isolated rat islets with CHIR-99021 can increase beta cell replication 2-3-fold, making this an important compound when studying type 1 and type 2 diabetes (2).

  1. Ring, D.B. et al. (2003) Diabetes 52, 588-95.
  2. Mussmann, R. et al. (2007) J Biol Chem 282, 12030-7.
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
To Purchase # 54290S
Product # Size Price
5 mg N/A

Powered by GlobalLink OneLink SoftwarePowered By OneLink